Statera Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	0.51	1.84	0.59	0	0.01
Short-Term Investments	-	0.13	-	-	-
Cash & Short-Term Investments	0.51	1.98	0.59	0	0.01
Cash Growth	-94.64%	233.29%	35892.06%	-85.03%	-
Receivables	0.36	0.35	0.33	-	-
Prepaid Expenses	0.1	0.98	-	-	-
Other Current Assets	0.26	0.85	0	-	0.42
Total Current Assets	1.22	4.16	0.93	0	0.43
Property, Plant & Equipment	1.02	1.17	0.11	-	-
Goodwill	9.27	9.27	-	-	-
Other Intangible Assets	1.24	1.58	-	-	-
Other Long-Term Assets	-	5	-	-	-
Total Assets	12.75	21.17	1.04	0	0.43
Accounts Payable	8.13	3.96	1.13	2.41	1.71
Accrued Expenses	6.31	1.75	1.55	-	-
Short-Term Debt	6.4	4.58	1.9	1.8	1.57
Current Portion of Leases	0.32	0.25	0.03	-	-
Current Unearned Revenue	0.39	0.37	-	-	-
Other Current Liabilities	0.68	0.33	-	-	-
Total Current Liabilities	22.23	11.25	4.62	4.21	3.29
Long-Term Debt	-	10.63	-	-	-
Long-Term Leases	0.69	0.81	0.07	-	-
Total Liabilities	22.92	22.68	4.69	4.21	3.29
Common Stock	0.25	0.18	0.16	0.02	0.02
Additional Paid-In Capital	133.53	127.74	23.95	11.31	9.43
Retained Earnings	-144.08	-129.48	-27.76	-15.54	-12.31
Comprensive Income & Other	0.05	-0.01	-	-	-
Total Common Equity	-10.24	-1.57	-3.66	-4.21	-2.86
Minority Interest	0.07	0.06	-	-	-
Shareholders' Equity	-10.17	-1.51	-3.66	-4.21	-2.86
Total Liabilities & Equity	12.75	21.17	1.04	0	0.43
Total Debt	7.41	16.26	2	1.8	1.57
Net Cash (Debt)	-6.9	-14.28	-1.41	-1.8	-1.56
Net Cash Per Share	-0.14	-0.41	-0.19	-0.09	-0.09
Filing Date Shares Outstanding	54.66	51.14	24.34	20.35	17.1
Total Common Shares Outstanding	50.74	35.48	24.34	20.35	17.1
Working Capital	-21.01	-7.09	-3.7	-4.21	-2.86
Book Value Per Share	-0.20	-0.04	-0.15	-0.21	-0.17
Tangible Book Value	-20.75	-12.42	-3.66	-4.21	-2.86
Tangible Book Value Per Share	-0.41	-0.35	-0.15	-0.21	-0.17
Machinery	-	0.23	0.01	-	-

Source: S&P Capital IQ. Standard template.